ClinicalTrials.gov
public full text
Public Domain
Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients
This study evaluates the efficacy of erythropoietin in refractory autoimmune encephalitis. Ten patients will receive 100 IU/kg of erythropoietin 3 times a week for 12 weeks.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical outcomes and prognostic factors after first- and second-line immunotherapy in a cohort of 57 patients with refractory autoimmune encephalitis.#1359214
- A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.#479377
- Autoimmune encephalitis in an underrepresented population : a case series from 2018 to 2023 in Bogotá, Colombia#341045
- Clonal hematopoiesis increases the risk of autoimmune hemolytic anemia#259261
- Autoimmune Encephalitis and Related Autoimmune Disorders of the Central Nervous System#473898
Record · ID 1438908
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive